{"DataElement":{"publicId":"7533445","version":"1","preferredName":"Disease or Disorder Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Classification Name","preferredDefinition":"Text term to represent the primary immunodeficiency syndrome or primary immune regulatory disorder classification.","longName":"PID_PIRD_CLASS_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7533431","version":"1","preferredName":"Disease or Disorder Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Classification","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Immunodeficiency disease that arises independent of another pathologic process, disease, or injury._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2404658v1.0:7533429v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7533429","version":"1","preferredName":"Primary Immunodeficiency Syndrome Or Primary Immune Regulatory Disorder Classification","preferredDefinition":"Immunodeficiency disease that arises independent of another pathologic process, disease, or injury.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C152105:C37998:C176600:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Immunodeficiency Syndrome","conceptCode":"C152105","definition":"Immunodeficiency disease that arises independent of another pathologic process, disease, or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary Immune Regulatory Disorder","conceptCode":"C176600","definition":"A group of immune diseases characterized predominantly by immune dysregulation leading to organ-specific autoimmunity, excessive inflammation, and non-malignant lymphoproliferation. Unlike classical primary immunodeficiencies, susceptibility to infections is typically less prominent in these disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683CDA7-24C5-6DB2-E053-4EBD850AC2A0","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683CDA7-24D6-6DB2-E053-4EBD850AC2A0","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeDescription":"2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7533437","version":"1","preferredName":"Immunodeficiency Name","preferredDefinition":"A disorder in which the immune system is unable to mount an adequate immune response._The words or language units by which a thing is known.","longName":"IMMUNODEF_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Congenital Defects of Phagocytes","valueDescription":"Congenital Defects of Phagocyte Number, Function, or Both","ValueMeaning":{"publicId":"7533439","version":"1","preferredName":"Congenital Defects of Phagocyte Number, Function, or Both","longName":"7533439","preferredDefinition":"A group of diseases or disorders caused by genetic defects within the immune system and comprising: Congenital neutropenia; Defects of motility; Defects of respiratory burst; and other nonlymphoid defects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Defects of Phagocyte Number, Function, or Both","conceptCode":"C176593","definition":"A group of diseases or disorders caused by genetic defects within the immune system and comprising: Congenital neutropenia; Defects of motility; Defects of respiratory burst; and other nonlymphoid defects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-EC4D-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-EC66-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"},{"value":"Diseases of Immune Dysregulation","valueDescription":"Immune Regulatory Disorder","ValueMeaning":{"publicId":"7533440","version":"1","preferredName":"Immune Regulatory Disorder","longName":"7533440","preferredDefinition":"A group of autoimmune disorders characterized by defects in self-tolerance (central or peripheral) resulting in autoimmune disease with or without recurrent infections, comprised by: Familial hemophagocytic lymphohistiocytosis (FHL) syndromes; FHL syndromes with hypopigmentation; Regulatory T cell (Treg) defects (eg, IPEX); Autoimmunity with or without lymphoproliferation (eg, autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy [APECED]); Autoimmune lymphoproliferative syndrome (ALPS); Immune dysregulation with colitis; and Susceptibility to Epstein-Barr virus (EBV) and lymphoproliferative conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Dysregulation Disorder","conceptCode":"C176595","definition":"A group of autoimmune disorders characterized by defects in self-tolerance (central or peripheral) resulting in autoimmune disease with or without recurrent infections, comprised by: Familial hemophagocytic lymphohistiocytosis (FHL) syndromes; FHL syndromes with hypopigmentation; Regulatory T cell (Treg) defects (eg, IPEX); Autoimmunity with or without lymphoproliferation (eg, autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy [APECED]); Autoimmune lymphoproliferative syndrome (ALPS); Immune dysregulation with colitis; and Susceptibility to Epstein-Barr virus (EBV) and lymphoproliferative conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-EC72-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-EC8B-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"},{"value":"Predominantly Antibody Deficiencies","valueDescription":"Predominantly Antibody Deficiencies","ValueMeaning":{"publicId":"7533441","version":"1","preferredName":"Predominantly Antibody Deficiencies","longName":"7533441","preferredDefinition":"A group of primary immunodeficiency diseases caused predominantly by antibody deficiencies, comprised of: Agammaglobulinemia with absent B cells; Severe reduction in at least two serum immunoglobulins, common variable immunodeficiency (CVID) phenotype; Severe reduction in serum IgG and IgA with normal or elevated IgM, hyper-IgM; and Isotype, light chain, or functional deficiencies with generally normal numbers of B cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Predominantly Antibody Deficiencies","conceptCode":"C176599","definition":"A group of primary immunodeficiency diseases caused predominantly by antibody deficiencies, comprised of: Agammaglobulinemia with absent B cells; Severe reduction in at least two serum immunoglobulins, common variable immunodeficiency (CVID) phenotype; Severe reduction in serum IgG and IgA with normal or elevated IgM, hyper-IgM; and Isotype, light chain, or functional deficiencies with generally normal numbers of B cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-EC95-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-ECAE-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"},{"value":"Immunodeficiencies Affecting Cellular and Humoral Immunity Associated with Syndromic Features","valueDescription":"Combined Immunodeficiencies Associated with Syndromic Features ","ValueMeaning":{"publicId":"7533442","version":"1","preferredName":"Combined Immunodeficiencies Associated with Syndromic Features ","longName":"7533442","preferredDefinition":"A group of genetic immunodeficiency syndromes with unique clinical features and well-characterized underlying immune defects, comprised of: CID with congenital thrombocytopenia; CID due to DNA repair defects other than forms of SCID in category I; CID due to thymic defects with additional congenital anomalies; CID with immunoosseous dysplasias; Hyper-IgE syndromes (HIES); CID due to defects of vitamin B12 and folate metabolism; Anhidrotic ectodermal dysplasia with immunodeficiency; CID due to calcium channel defects; and various other CID with unique clinical phenotypes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined Immunodeficiencies Associated with Syndromic Features","conceptCode":"C176596","definition":"A group of genetic immunodeficiency syndromes with unique clinical features and well-characterized underlying immune defects, comprised of: CID with congenital thrombocytopenia; CID due to DNA repair defects other than forms of SCID in category I; CID due to thymic defects with additional congenital anomalies; CID with immunoosseous dysplasias; Hyper-IgE syndromes (HIES); CID due to defects of vitamin B12 and folate metabolism; Anhidrotic ectodermal dysplasia with immunodeficiency; CID due to calcium channel defects; and various other CID with unique clinical phenotypes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-ECB8-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-ECD1-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"},{"value":"Immunodeficiencies Affecting Cellular and Humoral Immunity/ Combined Immune Deficiency","valueDescription":"Immunodeficiencies Affecting Cellular and Humoral Immunity - Combined Immune Deficiency","ValueMeaning":{"publicId":"7533443","version":"1","preferredName":"Immunodeficiencies Affecting Cellular and Humoral Immunity - Combined Immune Deficiency","longName":"7533443","preferredDefinition":"A group of immunodeficiency disorders that include combined immunodeficiencies (CIDs) generally less profound than SCID.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiencies Affecting Cellular and Humoral Immunity - Combined Immune Deficiency","conceptCode":"C176597","definition":"A group of immunodeficiency disorders that include combined immunodeficiencies (CIDs) generally less profound than SCID.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-ECDB-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-ECF4-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"},{"value":"Immunodeficiencies Affecting Cellular and Humoral Immunity/ Severe Combined Immune Deficiency","valueDescription":"Immunodeficiencies Affecting Cellular and Humoral Immunity - Severe Combined Immune Deficiency","ValueMeaning":{"publicId":"7533444","version":"1","preferredName":"Immunodeficiencies Affecting Cellular and Humoral Immunity - Severe Combined Immune Deficiency","longName":"7533444","preferredDefinition":"A group of immunodeficiency disorders that include T cell-negative, B cell-positive severe combined immunodeficiencies; and T cell-negative, B cell-negative severe combined immunodeficiencies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiencies Affecting Cellular and Humoral Immunity - Severe Combined Immune Deficiency","conceptCode":"C176598","definition":"A group of immunodeficiency disorders that include T cell-negative, B cell-positive severe combined immunodeficiencies; and T cell-negative, B cell-negative severe combined immunodeficiencies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-ECFE-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-ED17-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"},{"value":"Defects of Intrinsic and Innate Immunity","valueDescription":"Defects of Intrinsic and Innate Immunity","ValueMeaning":{"publicId":"7533438","version":"1","preferredName":"Defects of Intrinsic and Innate Immunity","longName":"7533438","preferredDefinition":"A group of diseases or disorders caused by genetic defects within the immune system, comprised by: Mendelian susceptibility to mycobacterial disease (MSMD); Epidermodysplasia verruciformis (HPV); Predisposition to severe viral infection; Herpes simplex encephalitis (HSE); Predisposition to invasive fungal diseases; Predisposition to mucocutaneous candidiasis; TLR signaling pathway deficiencies with bacterial susceptibility; and other inborn errors of immunity related to nonhematopoietic tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Defects in Intrinsic and Innate Immunity","conceptCode":"C176594","definition":"A group of diseases or disorders caused by genetic defects within the immune system, comprised by: Mendelian susceptibility to mycobacterial disease (MSMD); Epidermodysplasia verruciformis (HPV); Predisposition to severe viral infection; Herpes simplex encephalitis (HSE); Predisposition to invasive fungal diseases; Predisposition to mucocutaneous candidiasis; TLR signaling pathway deficiencies with bacterial susceptibility; and other inborn errors of immunity related to nonhematopoietic tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-EC28-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B683FD01-EC41-6217-E053-4EBD850AD061","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7533436","version":"1","preferredName":"Immunodeficiency Name","preferredDefinition":"A disorder in which the immune system is unable to mount an adequate immune response.:The words or language units by which a thing is known.","longName":"C39725:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency","conceptCode":"C39725","definition":"A disorder in which the immune system is unable to mount an adequate immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-EC00-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"ONEDATA","dateModified":"2020-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B683FD01-EC11-6217-E053-4EBD850AD061","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"KUMMEROA","dateModified":"2021-01-14","changeDescription":"2021-1-14 ak Added missing PV concepts. 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Classification","type":"Preferred Question Text","description":"Classification","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6841741-B18A-6D86-E053-4EBD850AC78E","latestVersionIndicator":"Yes","beginDate":"2020-12-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-12-15","modifiedBy":"COOPERM","dateModified":"2020-12-23","changeDescription":"Approved for import and released. mc 12.23.2020; 2020-12-15 AK Created for NCI-INC0536652 - 20C0070 Curation and import 11.10.2020","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}